WaferGen Amends Agreement with Malaysian Investor | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Wafergen Biosystems has amended an existing agreement with its Malaysian subsidiary and the Malaysian Technology Development Corporation to change certain rights and obligations related to certain classes of Wafergen Malaysia's stock.

MDTC is a venture capital and development firm and an investor in WaferGen Malaysia.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.